[go: up one dir, main page]

DK170186D0 - Biologisk ren kultur af en stamme lactobacillus acidophilus samt fremgangsmaade til isolering af en saadan kultur og anvendelse af denne somlaegemiddel - Google Patents

Biologisk ren kultur af en stamme lactobacillus acidophilus samt fremgangsmaade til isolering af en saadan kultur og anvendelse af denne somlaegemiddel

Info

Publication number
DK170186D0
DK170186D0 DK170186A DK170186A DK170186D0 DK 170186 D0 DK170186 D0 DK 170186D0 DK 170186 A DK170186 A DK 170186A DK 170186 A DK170186 A DK 170186A DK 170186 D0 DK170186 D0 DK 170186D0
Authority
DK
Denmark
Prior art keywords
culture
bacteria
lactobacillus acidophilus
biologically
treasure
Prior art date
Application number
DK170186A
Other languages
English (en)
Other versions
DK171369B1 (da
DK170186A (da
Inventor
Sherwood L Gorbach
Barry R Goldin
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24909071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK170186(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Publication of DK170186D0 publication Critical patent/DK170186D0/da
Publication of DK170186A publication Critical patent/DK170186A/da
Application granted granted Critical
Publication of DK171369B1 publication Critical patent/DK171369B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK170186A 1985-04-17 1986-04-15 Biologisk ren kultur af en stamme af Lactobacillus acidophilus, fremgangsmåde til isolering af en sådan kultur og terapeutisk præparat indeholdende denne DK171369B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72411485 1985-04-17
US06/724,114 US4839281A (en) 1985-04-17 1985-04-17 Lactobacillus strains and methods of selection

Publications (3)

Publication Number Publication Date
DK170186D0 true DK170186D0 (da) 1986-04-15
DK170186A DK170186A (da) 1986-10-18
DK171369B1 DK171369B1 (da) 1996-09-30

Family

ID=24909071

Family Applications (1)

Application Number Title Priority Date Filing Date
DK170186A DK171369B1 (da) 1985-04-17 1986-04-15 Biologisk ren kultur af en stamme af Lactobacillus acidophilus, fremgangsmåde til isolering af en sådan kultur og terapeutisk præparat indeholdende denne

Country Status (9)

Country Link
US (2) US4839281A (da)
EP (1) EP0199535B2 (da)
JP (1) JPH0648979B2 (da)
AT (1) ATE71140T1 (da)
AU (1) AU597882B2 (da)
DE (1) DE3683184D1 (da)
DK (1) DK171369B1 (da)
FI (1) FI90086C (da)
NO (1) NO169241C (da)

Families Citing this family (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US4980164A (en) * 1986-10-02 1990-12-25 Bio Techniques Laboratories, Inc. Strains of lactobacillus for enhancing feed conversion efficiency
CH674150A5 (da) * 1987-10-30 1990-05-15 2 Oi Mo G Med I Im N I Pirogov
DK686187D0 (da) * 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
WO1989011858A1 (en) * 1988-06-09 1989-12-14 Whitecliffe Laboratories Limited Treatment of immunodeficiency
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
DE69122186T2 (de) * 1990-01-31 1997-03-27 San Ei Sucrochemical Co Ltd Laktobazillus acidophilus-f-133, herstellung von davon ausgehenden milchsäurebakterien und verfahren zu deren herstellung
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
ES2102485T3 (es) * 1992-07-06 1997-08-01 Nestle Sa Bacteria lactica.
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
WO1994018997A1 (en) * 1993-02-24 1994-09-01 Valio Ltd. Method of enhancing immune response to oral vaccines
JP2824821B2 (ja) * 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
US5434765A (en) * 1994-03-10 1995-07-18 Holophane Corporation Luminaire assembly
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
ATE163042T1 (de) * 1994-05-26 1998-02-15 Bracco Spa Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
US6036669A (en) 1995-01-13 2000-03-14 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US6277092B1 (en) 1995-01-13 2001-08-21 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
FI104465B (fi) † 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
IT1276783B1 (it) * 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
FR2740471B1 (fr) * 1995-10-31 1997-12-19 Gervais Danone Co Ferments lactiques, et leur utilisation pour l'obtention de produits hypocholesterolemiants
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
ES2243965T3 (es) * 1996-07-09 2005-12-01 Societe Des Produits Nestle S.A. Procedimiento de secado mediante pulverizacion.
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
DE69712503T2 (de) * 1996-09-06 2002-08-29 Societe Des Produits Nestle S.A., Vevey Belüftetes speiseeis mit milchsäurebakterien enthaltende beschichtung
GB9623068D0 (en) * 1996-11-06 1997-01-08 Cultech Limited Microflora
EP1728855A1 (en) * 1996-11-29 2006-12-06 Bio-K Plus International, Inc. Lactic ferment comprising a particular strain of lactobacillus acidopuilus and use thereof
AU5113798A (en) 1996-11-29 1998-06-22 Bio K & International Inc. Lactic ferment comprising a particular strain of (lactobacillus acidophilus) and use thereof
NZ337505A (en) * 1997-02-11 2001-07-27 Univ College Cork Nat Univ Ie Isolated antimicrobial agents from Lactobacillus salivarius
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
BR9811662A (pt) 1997-07-05 2000-09-19 Nestle Sa "sobremesa congelada."
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US7029702B2 (en) 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
EP1104281B1 (en) 1998-08-12 2011-03-16 Societe Des Produits Nestle S.A. Incorporation of exogenous lactic bacteria into the oral microflora
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
FR2785809B1 (fr) 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
IT1312098B1 (it) * 1999-04-23 2002-04-04 Proge Farm Srl Metodo di selezione di ceppi di lattobacilli adesivi con proprieta'terapeutiche e ceppi ottenuti con tale metodo.
US20040197352A1 (en) * 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
US7998470B2 (en) * 1999-04-30 2011-08-16 Kibow Biotech, Inc. Compositions and methods improving renal function
RU2146454C1 (ru) * 1999-05-18 2000-03-20 Анисимова Таисия Ивановна Штамм бактерий lactobacillus acidophilus n.v.ep 317/402 "наринэ" ааа, используемый при приготовлении препаратов, диетических и лечебно-профилактических продуктов для лечения дисбактериоза и его последствий
IL130303A0 (en) 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
US6251432B1 (en) 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
DE19963104A1 (de) * 1999-12-24 2001-06-28 Ralf Kirkamm Mittel zur Behandlung von Bakterienmangel
JP2003535903A (ja) * 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
IT1320772B1 (it) * 2000-11-02 2003-12-10 Proge Farm Srl Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
US7214370B2 (en) * 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
EP1345613B1 (en) 2000-12-18 2008-04-09 Probio Health Probiotic compounds derived from lactobacillus casei strain ke01
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
ATE409220T1 (de) * 2002-03-21 2008-10-15 Bifodan As Lactobacillus-stämme
US7300787B2 (en) * 2002-07-05 2007-11-27 Archer-Daniels-Midland Company Lactobacillus strains and use thereof in fermentation for L-lactic acid production
JP4618970B2 (ja) * 2002-08-02 2011-01-26 マルホ株式会社 肛門圧低下外用剤
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
FI113057B (fi) * 2002-11-04 2004-02-27 Valio Oy Menetelmä hiivojen kasvun estämiseksi
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
EP3184275B1 (en) 2003-05-22 2020-04-29 Canco Hungary Investment Ltd. Polymeric articles
WO2005032591A1 (en) 2003-09-30 2005-04-14 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
RU2006140784A (ru) * 2004-04-20 2008-05-27 Дзе Юниверсити Оф Чикаго (Us) Терапевтическая система доставки, содержащая высокомолекулярное пэг-подобное соединение
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
DK1858340T3 (da) * 2005-02-15 2010-09-27 Barry R Goldin Fødevare, der indeholder en probiotisk og en isoleret beta-glucan, og fremgangsmåder til anvendelse deraf
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
EP2270131A1 (en) 2005-05-31 2011-01-05 The Iams Company Feline probiotic lactobacilli
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
PL2604689T3 (pl) 2005-07-26 2015-08-31 Nestec Ltd Środek zapobiegający otyłości oraz zapobiegająca otyłości żywność
SI1931363T1 (sl) 2005-09-28 2016-02-29 Nordisk Rebalance A/S Zdravljenje vnetnih črevesnih bolezni z uporabo probiotičnih bakterij in fermentiranega žita kot efektorjev zdravljenja
CN101420965B (zh) 2006-02-15 2013-08-07 雀巢产品技术援助有限公司 长双歧杆菌在制备预防和治疗炎症的药物中的用途
CN101432007A (zh) 2006-03-07 2009-05-13 雀巢产品技术援助有限公司 合益素混合物
JP2009529574A (ja) * 2006-03-10 2009-08-20 エヌ．ブイ．・ヌートリシア 誕生後に乳児に最良の始まりを与えるための難消化性糖類の使用
AU2013201783B2 (en) * 2006-10-02 2015-06-04 International N&H Denmark Aps Probiotics for use in reducing the incidence and duration of illness
US7387427B2 (en) * 2006-10-20 2008-06-17 Bristol-Myers Squibb Company Method for blending heat-sensitive material using a conical screw blender with gas injection
US20080095752A1 (en) * 2006-10-20 2008-04-24 Win-Chin Chiang Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
CA2712207A1 (en) 2008-01-24 2009-07-30 Nestec S.A. Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
FI121912B (fi) * 2008-02-05 2011-06-15 Valio Oy Probioottien uusi käyttö
AU2009224814B2 (en) 2008-03-14 2015-02-05 Société des Produits Nestlé S.A. Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
AU2010209584C1 (en) 2009-02-02 2016-09-08 Chr. Hansen A/S Lactobacillus rhamnosus pilus polypeptides and methods for producing them
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FI121952B (fi) 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB0914878D0 (en) 2009-08-26 2009-09-30 Plant Bioscience Ltd Competetive exclusion compositions and methods
EP2295535A1 (en) 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20140093614A1 (en) 2009-09-20 2014-04-03 Mead Johnson Nutrition Company Probiotic stabilization
US20110070334A1 (en) 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
FI20096058A0 (fi) 2009-10-13 2009-10-13 Valio Oy Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
CN102665428A (zh) 2009-12-08 2012-09-12 雀巢产品技术援助有限公司 含有益生菌和乳脂肪球膜组分的婴儿配方
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
WO2011141762A1 (en) 2010-05-12 2011-11-17 Compagnie Gervais Danone Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei
US9474298B2 (en) 2011-10-11 2016-10-25 Mead Johnson Nutrition Company Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
WO2013148258A1 (en) 2012-03-29 2013-10-03 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US20130344042A1 (en) 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
KR102324015B1 (ko) * 2012-09-25 2021-11-10 아퀼론 씨와이엘 에스.엘. 프로바이오틱 및 프리바이오틱 조성물
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA3212215A1 (en) 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3587558A3 (en) 2013-02-04 2020-03-04 Seres Therapeutics, Inc. Methods of populating a gastrointestinal tract
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
CA2904389C (en) 2013-03-14 2018-09-18 Jerome J. Schentag Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
EP2967077A4 (en) 2013-03-15 2016-09-14 Seres Therapeutics Inc NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
JP2016531131A (ja) 2013-08-22 2016-10-06 ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオーＮｅｄｅｒｌａｎｄｓｅ Ｏｒｇａｎｉｓａｔｉｅ ｖｏｏｒ ｔｏｅｇｅｐａｓｔ−ｎａｔｕｕｒｗｅｔｅｎｓｃｈａｐｐｅｌｉｊｋ ｏｎｄｅｒｚｏｅｋ ＴＮＯ ヒト又は動物の微生物叢由来の有利な微生物のｉｎ ｖｉｔｒｏの濃縮によるプロバイオティクスの生成
KR102379658B1 (ko) 2013-11-25 2022-03-28 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
US20150305359A1 (en) 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
IL298281A (en) 2015-11-03 2023-01-01 Brigham & Womens Hospital Inc Medical microbiota for the treatment and/or prevention of food allergy
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
JP2018537084A (ja) 2015-11-09 2018-12-20 エム・ジェイ・エヌ ユー．エス． ホールディングス リミテッド ライアビリティー カンパニー カゼイン加水分解物並びに食品酪酸塩および／または内因性酪酸塩の形成を刺激するための化合物を含む栄養組成物
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
EP3554517B1 (en) 2016-12-16 2023-09-13 Compagnie Gervais Danone Probiotic composition comprising lactobacillus rhamnosus and lactobacillus paracasei strains
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
DE102017113263A1 (de) 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
WO2019036510A1 (en) 2017-08-14 2019-02-21 Seres Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATING CHOLESTATIC DISEASE
KR20200079292A (ko) 2017-10-30 2020-07-02 세레스 테라퓨틱스, 인코포레이티드 항생제 내성을 치료하기 위한 조성물 및 방법
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
CN113194971A (zh) 2018-09-10 2021-07-30 拉克托拜欧有限公司 用于减少病原微生物转移的方法
WO2020127637A1 (en) 2018-12-21 2020-06-25 Lactobio Aps Topical composition comprising viable microorganisms
JP2022517754A (ja) 2019-01-04 2022-03-10 ラクトバイオ アー／エス 菌株、組成物および使用方法
US20220211782A1 (en) 2019-05-20 2022-07-07 Lactobio A/S Composition for treatment, alleviation or prophylaxis of acne
WO2020246585A1 (ja) 2019-06-05 2020-12-10 森永乳業株式会社 栄養組成物
CN114245748A (zh) 2019-06-13 2022-03-25 莱托生物股份有限公司 包含活微生物的凝胶组合物
EP4393321A3 (en) 2019-07-23 2024-08-28 FrieslandCampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
WO2024245585A1 (en) 2023-05-30 2024-12-05 L'oréal Topical formulation comprising deliquescent substance
WO2025036982A1 (en) 2023-08-16 2025-02-20 L'oréal New container, method and delivery system stabilizing topical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294835A (da) * 1962-07-19 1900-01-01
LU44002A1 (da) * 1962-07-19 1963-09-03
DE1617755A1 (de) * 1966-10-21 1972-02-17 Rehm Eberhard Verfahren zur Herstellung eines durch selektive Zuechtung von Laktobakterien erhaltenen Praeparates
GB1167196A (en) * 1966-12-12 1969-10-15 Yakult Honsha Kk Lactic Acid Bacteria.
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
IT1141095B (it) * 1980-11-27 1986-10-01 Ravizza Spa Processo di risoluzione della sulpiride racema
US4525351A (en) * 1983-01-11 1985-06-25 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection

Also Published As

Publication number Publication date
NO169241B (no) 1992-02-17
JPH0648979B2 (ja) 1994-06-29
EP0199535A2 (en) 1986-10-29
NO861483L (no) 1986-10-20
FI860194A (fi) 1986-10-18
NO169241C (no) 1992-05-27
EP0199535A3 (en) 1988-08-03
FI90086B (fi) 1993-09-15
FI90086C (fi) 1993-12-27
FI860194A0 (fi) 1986-01-16
DE3683184D1 (de) 1992-02-13
AU5611286A (en) 1987-10-22
ATE71140T1 (de) 1992-01-15
US4839281A (en) 1989-06-13
DK171369B1 (da) 1996-09-30
AU597882B2 (en) 1990-06-14
EP0199535B1 (en) 1992-01-02
DK170186A (da) 1986-10-18
US5032399A (en) 1991-07-16
EP0199535B2 (en) 1995-11-02
JPS61280433A (ja) 1986-12-11

Similar Documents

Publication Publication Date Title
DK170186D0 (da) Biologisk ren kultur af en stamme lactobacillus acidophilus samt fremgangsmaade til isolering af en saadan kultur og anvendelse af denne somlaegemiddel
Young et al. Interactions of oral strains of Candida albicans and lactobacilli
NO306699B1 (no) Tarmkanal-koloniserende lactobasiller, samt fremgangsmåte for isolering og anvendelse derav, samt blanding
DE3888642D1 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
HUP9900768A2 (hu) Photorhabdusból származó inszekticid protein toxinok
DK6081A (da) Fremgangsmaade til fremstilling af et bakteriepraeparat
IL78197A (en) Nucleic acid encoding tgf-beta and its uses
Payne et al. Siderophore production by Vibrio cholerae
Swift et al. Pathogenic pleuropneumonia-like microorganisms from acute rheumatic exudates and tissues
Tsukamura Properties of Mycobacterium smegmatis freshly isolated from soil
ES8800275A1 (es) Procedimiento para la preparacion de nuevos antigenos nativos pseudomonas-flagella (h)
JPS56147706A (en) Humectant for skin
Okubo et al. Evidence of transformation in Micrococcuslysodeikticus
IL59724A0 (en) Pentadecapeptide and its salts,their preparation and pharmaceutical compositions containing them
FR2589063B1 (fr) Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
SU1692021A3 (ru) Способ получения лечебно-профилактического препарата для нормализации микрофлоры кишечника на основе бактерий рода bifidobacterium
JPS56140888A (en) Preparation of limiting enzyme
Jordan et al. The utilization of peptides and L-and D-amino acids by effective and ineffective strains of Rhizobium meliloti
FR2603040B1 (fr) Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose
Birnbaum et al. Metabolism of Biotin and Analogues of Biotin by Microorganisms III. Degradation of Oxybiotin and Desthiobiotin by Lactobacillus plantarum
束村道雄 et al. DIFFERENTIATION AMONG MYCOBACTERIUM, RHODOCOCCUS (GORDONA) AND NOCARDIA BY THIN-LAYER CHROMATOGRAPHY AFTER INCUBATION WITH ACETATE-1-14C
JPS56154992A (en) Heat-resistant immobilized acetate kinase
Brown Studies on transformation in streptococci
Schneider-Schaulies et al. Induction of c-onc expression in polyclonally activated mouse lymphocytes
SU1817285A1 (ru) Способ приготовления закваски для производства кисломолочных продуктов

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
B1 Patent granted (law 1993)
PBP Patent lapsed
PBP Patent lapsed